The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-{4-[2-(3,5-dimethoxy-phenyl)-vinyl]-indol-1yl}-butyl)-4-methyl-benzenesulfonamide ID: ALA3344401
PubChem CID: 118717760
Max Phase: Preclinical
Molecular Formula: C29H32N2O4S
Molecular Weight: 504.65
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(/C=C/c2cccc3c2ccn3CCCCNS(=O)(=O)c2ccc(C)cc2)cc(OC)c1
Standard InChI: InChI=1S/C29H32N2O4S/c1-22-9-13-27(14-10-22)36(32,33)30-16-4-5-17-31-18-15-28-24(7-6-8-29(28)31)12-11-23-19-25(34-2)21-26(20-23)35-3/h6-15,18-21,30H,4-5,16-17H2,1-3H3/b12-11+
Standard InChI Key: MKSOLNWGSYDLBC-VAWYXSNFSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
26.7857 -10.8092 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.0003 -11.6016 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
27.5793 -11.0196 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.6541 -14.7012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6530 -15.5207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3611 -15.9297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3593 -14.2923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0679 -14.6976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0681 -15.5162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8468 -15.7689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3278 -15.1065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8464 -14.4444 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.3632 -16.7468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6566 -17.1573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6588 -17.9745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9507 -18.3837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9525 -19.2001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6619 -19.6077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3708 -19.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3655 -18.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0986 -13.6671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8979 -13.4969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1502 -12.7197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9494 -12.5495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2457 -19.6103 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.5371 -19.2032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0811 -19.5970 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.0861 -20.4141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2017 -11.7722 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5480 -12.2091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2942 -12.9862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8405 -13.5930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6407 -13.4231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8918 -12.6409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3438 -12.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1885 -14.0294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
6 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
12 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
17 25 1 0
25 26 1 0
19 27 1 0
27 28 1 0
24 29 1 0
29 2 1 0
2 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
33 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 504.65Molecular Weight (Monoisotopic): 504.2083AlogP: 5.90#Rotatable Bonds: 11Polar Surface Area: 69.56Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.40CX Basic pKa: ┄CX LogP: 6.04CX LogD: 6.04Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.20Np Likeness Score: -1.12
References 1. Ferla S, Gomaa MS, Brancale A, Zhu J, Ochalek JT, DeLuca HF, Simons C.. (2014) Novel styryl-indoles as small molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): Synthesis and biological evaluation., 87 [PMID:25240094 ] [10.1016/j.ejmech.2014.09.035 ] 2. Bruno, Robert D RD and Njar, Vincent C O VC. 2007-08-01 Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. [PMID:17544277 ] 3. Taban, Ismail M IM, Zhu, Jinge J, DeLuca, Hector F HF and Simons, Claire C. 2017-08-01 Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides. [PMID:28601511 ]